Imugene Ltd., Aventis, Merck deal

Merial Ltd. (London, U.K.), a joint venture between MRK and AVE, will evaluate IMU's adenoviral vector to treat and prevent poultry diseases. In addition, the companies will evaluate the use of the ve...